Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer
Clinical trial NCT02317991 · COMPLETED
Trial details
- NCT number
- NCT02317991
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-05
- Primary completion
- 2021-05-21
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.